Literature DB >> 15480961

Tuberculosis in children: considerations for children from developing countries.

Lisa J Nelson1, Charles D Wells.   

Abstract

Although accurate data are scarce for children, tuberculosis (TB) represents one of the most common infectious causes of morbidity and mortality worldwide. TB case rates have declined among children in the United States in the last decade, but they remain high among children from low-income countries and racial or ethnic minorities. Establishing the definitive diagnosis of TB in a child remains difficult and frequently relies on a constellation of history, clinical findings, and bacteriology. Recently, updated national and international treatment recommendations have been published. Contact investigation and treatment using directly observed therapy are important components of the optimal case detection and management of TB in children.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15480961     DOI: 10.1053/j.spid.2004.05.007

Source DB:  PubMed          Journal:  Semin Pediatr Infect Dis        ISSN: 1045-1870


  10 in total

1.  CD8+ T cells provide an immunologic signature of tuberculosis in young children.

Authors:  Christina Lancioni; Melissa Nyendak; Sarah Kiguli; Sarah Zalwango; Tomi Mori; Harriet Mayanja-Kizza; Stephen Balyejusa; Megan Null; Joy Baseke; Deo Mulindwa; Laura Byrd; Gwendolyn Swarbrick; Christine Scott; Denise F Johnson; LaShaunda Malone; Philipa Mudido-Musoke; W Henry Boom; David M Lewinsohn; Deborah A Lewinsohn
Journal:  Am J Respir Crit Care Med       Date:  2011-10-27       Impact factor: 21.405

Review 2.  Active case finding of tuberculosis: historical perspective and future prospects.

Authors:  J E Golub; C I Mohan; G W Comstock; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2005-11       Impact factor: 2.373

3.  Progressive primary pulmonary tuberculosis presenting as the sudden unexpected death in infancy: a case report.

Authors:  Johan Dempers; Mary Ann Sens; Shabbir Ahmed Wadee; Hannah C Kinney; Hein J Odendaal; Colleen A Wright
Journal:  Forensic Sci Int       Date:  2010-08-11       Impact factor: 2.395

4.  Predictors of evaluation in child contacts of TB patients.

Authors:  G Lee; A J Meyer; S Kizito; A Katamba; J L Davis; M Armstrong-Hough
Journal:  Int J Tuberc Lung Dis       Date:  2020-08-01       Impact factor: 2.373

Review 5.  Recent advances in the diagnosis of childhood tuberculosis.

Authors:  Ben J Marais; Madhukar Pai
Journal:  Arch Dis Child       Date:  2007-05       Impact factor: 3.791

6.  Classic and new diagnostic approaches to childhood tuberculosis.

Authors:  Gladys Guadalupe López Ávalos; Ernesto Prado Montes de Oca
Journal:  J Trop Med       Date:  2012-03-12

7.  Examining the quality of childhood tuberculosis diagnosis in Cambodia: a cross-sectional study.

Authors:  Julia B Frieze; Rajendra-Prasad Yadav; Khann Sokhan; Song Ngak; Team Bak Khim
Journal:  BMC Public Health       Date:  2017-03-06       Impact factor: 3.295

8.  Whole blood interferon-gamma responses to mycobacterium tuberculosis antigens in young household contacts of persons with tuberculosis in Uganda.

Authors:  Deborah A Lewinsohn; Sarah Zalwango; Catherine M Stein; Harriet Mayanja-Kizza; Alphonse Okwera; W Henry Boom; Roy D Mugerwa; Christopher C Whalen
Journal:  PLoS One       Date:  2008-10-15       Impact factor: 3.240

9.  Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy.

Authors:  Elisabetta Walters; Mark F Cotton; Helena Rabie; H Simon Schaaf; Lourens O Walters; Ben J Marais
Journal:  BMC Pediatr       Date:  2008-01-11       Impact factor: 2.125

10.  Improving pediatric TB diagnosis in North Kivu (DR Congo), focusing on a clinical algorithm including targeted Xpert MTB/RIF on gastric aspirates.

Authors:  Daan Van Brusselen; Erica Simons; Tony Luendo; Delphine Habarugira; Jimmy Ngowa; Nadine Neema Mitutso; Zakari Moluh; Mieke Steenssens; Rachelle Seguin; Hilde Vochten; Lucien Ngabo; Petros Isaakidis; Gabriella Ferlazzo
Journal:  Confl Health       Date:  2020-05-14       Impact factor: 2.723

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.